You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
URBAN TRANSIT COST RECOVERY FEASIBILITY STUDY
SBC: Williams-kuebelbeck & Assc Inc Topic: N/AURBAN TRANSIT IMPROVEMENTS ENHANCE THE VALUE OF THE PROPERTY THEY SERVE. TRADITIONAL URBAN TRANSIT FINANCING TECHNIQUES NEGLECT THIS POTENTIAL SOURCE OF REVENUE. BENEFIT ASSESSMENT DISTRICTS AND IMPACT MITIGATION FEES, BASED ON CONCEPTS ORIGINALLY DEVISED FOR MINOR IMPROVEMENTS (EG. SIDEWALKS), HAVE BEEN APPLIED EXPERIMENTALLY TO URBAN TRANSIT, BUT DO NOT GENERATE THE MAJOR FUNDING URBAN TRANSIT R ...
SBIR Phase I 1987 Department of Transportation -
Restoring diabetic tactile sense using mechanical noise
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): More than 10 million individuals in the U.S. are thought to suffer from diabetic neuropathies. Many serious medical problems stem from this condition, including degradation of the mechanical senses of touch and propri
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Implantable Noise-based Sensory Enhancement Devices
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly impacts quality of life while generating tremendous ongoing health care costs and losses to productivity. Recent scientific and clinical findings have ...
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Implantable Noise-based Sensory Enhancement Devices
SBC: AFFERENT CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly imp
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
TRACHEAL GAS INSUFFLATION- PATIENT INTERFACE SYSTEM
SBC: ALVEOLI MEDICAL, LLC Topic: N/ADESCRIPTION (provided by applicant): The benefits of Tracheal Gas Insufflation (TGI) as an adjunct to mechanical ventilation are well known. 1 TGI reduces dead space and CO2 rebreathing in mechanically ventilated patients, thereby reducing PaCO2 with no c
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Indicator cells for antiviral screening for filoviruses
SBC: APATH, LLC Topic: N/ADESCRIPTION (provided by applicant): Filoviruses include some of the most notorious human pathogens and cause significant morbidity and mortality due to severe hemorrhagic fever syndromes. Unfortunately, very few therapeutic agents are available to treat
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Transgenic indicator cells for influenza virus
SBC: APATH, LLC Topic: N/ADESCRIPTION (provided by applicant): Influenza virus causes a pandemic disease of the respiratory tract that results in significant human morbidity and mortality. Diagnosis of influenza virus infection during the winter months makes up a large component
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Replicon-based screening for inhibitors of alphaviruses
SBC: APATH, LLC Topic: N/ADESCRIPTION (provided by applicant): The goal in this study is to develop a cell-based assay to screen compounds for antiviral activity against certain members of the Togavirus family. We are particularly targeting the more pathogenic encephalitis-causing
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Production of human CD39 as an antithrombotic agent
SBC: APT THERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Production of a human apyrase protein as an antithrombotic agent is proposed. Thrombotic vascular occlusion due to abnormal platelet aggregation can lead to many diseases, including ischemic stroke, myocardial infarcti
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
LOW-COST BIOSENSOR FOR REAL-TIME DIAGNOSIS OF BACTEREMIA
SBC: BCR DIAGNOSTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): BCR Diagnostics, Inc. (BCR) proposes to study the feasibility of applying its low-cost biosensor technology to detecting bacteremia in real-time (i.e., less than 5 min). The premise underlying the application is that
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health